The Use of Folic Acid in Chronic Kidney Disease Patients With Anemia

Chronic kidney disease (CKD) is defined as decreasing function (GFR < 60 ml/minute/1.73 m2 ) for more than 3 months. Anemia a common complication of CKD due to decrease in the hormone erythropoietin related hemoglobin levels. One anemia therapies involves using folic acid. Folic acid helps process nucleoprotein synthesis and erythropoiesis maintenance. The objective this study was determine pattern applied patients with at University Muhammadiyah Malang General Hospital. Observational, descriptive, retrospective data collection methods were used. results showed that there 17 (47%) single use (3x1 mg, oral); most two-combination oral) PRC (250 ml, intravenous [iv]), which given 11 (65%); threecombination oral), Promavit® tab, iv), 2 or 100%. Of 16 switch patterns, combination 7 (44%).
 Keywords: acid, anemia, chronic